Refine by
Medical Power Articles & Analysis
32 news found
“For instance, morphine is one of the most known alkaloids which had been used and still is for medical purposes. This alkaloid is a powerful narcotic used for the relief of pain. ...
These research and development activities to be presented at ECR showcase Bayer’s advanced position in digital and AI powered medical imaging, bolstered by the recent acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis as well as the recent launch of CalanticTM Digital Solutions – a new platform delivering ...
ByBayer AG
The FC1500 delivers constant charge power and eliminates the need for multiple power supplies in medical laser and Intense Pulsed Light Therapy (IPL) equipment. ...
BOSTON – November 4, 2022 – Elucid, Inc., a medical technology company providing physicians AI-powered imaging analysis software to characterize cardiovascular disease, has announced that the company’s technology will be featured on the program at the 2022 American Heart Association (AHA) Scientific Sessions, November 5-7, 2022 in Chicago. ...
ByElucid
Quantum points have revealed great potential in analytical applications, but their emission wavelengths in the visible region limit their application, especially in fluorescence imaging for medical diagnostics. Given this, researchers often systematically tune quantum dots to emit different wavelengths, from the visible to the near-infrared region, by adjusting their particle ...
With an expert R&D team and a licenced manufacturing facility with a 50 million+ annual thin film capacity, the Firm is an ideal potential partner to produce XPhyto’s oral dissolvable (“ODF”) biosensor products. They are capable of thin film medical product formulation, mixing, coating, and packaging. In addition, the Firm has a portfolio of OTC and ...
Certain buprenorphine medicines prescribed to treat opioid use disorder (“OUD”) and pain have been recently associated with numerous serious oral health problems requiring medical intervention. Buprenorphine is a medication approved by the U.S. ...
Transpara's developers, ScreenPoint Medical is expanding its operations in the US to meet customer demand and its success has meant the company has also attracted a $28 million capital injection from Insight Partners and URG to help it expand. ...
Unilabs, the leading diagnostic services provider, announced a partnership with Subtle Medical, a healthcare technology company using artificial intelligence for faster and higher quality MRI, to further improve the quality and efficiency of their MRI imaging. ...
Subtle Medical, a key provider of artificial intelligence (AI) solutions for medical imaging, and Siemens Healthineers, a leading medical technology company, officially announced the integration of Subtle Medical’s SubtleMR™ image-enhancement software into the new reconstruction pipeline of Siemens Healthineers, Open ...
STEMart, a provider of integrated medical device CRO services dedicated to medical device and diagnostic clinical development, expands its Biocompatibility Testing services and introduces biocompatibility evaluation of breathing gas pathways in medical devices. This new testing follows the biocompatibility guidelines modified for ...
BySTEMart
Clairvo Technologies, Inc., a wholly owned subsidiary of Marubeni Corporation, secured the certification from Japan’s Pharmaceuticals and Medical Devices Agency. “I am pleased that VIDA has obtained market authorization in Japan, where lung disease is a major and growing health crisis,” said Yasutaka Nakano, MD, PhD Professor and Chairman, Division of ...
PARIS, FRANCE, March 3, 2022, PRNewswire – Qynapse SAS, a medical technology company commercializing an FDA approved/CE cleared AI-powered neuroimaging software platform for central nervous system (CNS) disorders, is pleased to announce that a symposium oral presentation and a poster presentation will be delivered at the upcoming AD/PD™ 2022 ...
ByQynapse
BOSTON, MA, February 14, 2022, PRNewswire – Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, is pleased to present 2 posters at the annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2022, on February 24-26, in West ...
ByQynapse
“We are pleased to collaborate with Subtle Medical to harness the power of AI, with the ultimate goal of providing physicians with the means for optimal diagnosis for their ...
Subtle Medical, a key provider of artificial intelligence (AI) solutions for medical imaging, and Siemens Healthineers, a leading medical technology company, announced today a partnership to integrate Subtle Medical’s SubtleMR™ image-enhancement software into the MRI machines of Siemens Healthineers. ...
Invenia ABUS 2.0 is the first FDA-approved Ultrasound supplemental breast screening technology specifically designed for detecting cancer in dense breast tissue. The powerful AI Assistant leverages intelligent algorithms to assist in detecting breast lesions, helping physicians increase their reading speed with confidence. ...
BOSTON, MA, November 22, 2021, PRNewswire – Qynapse Inc., a medical technology company commercializing an artificial intelligence (AI)-powered neuroimaging software platform for central nervous system (CNS) disorders, will unveil its new brand and latest AI developments as a key exhibitor in the AI Showcase at the 107th Radiology Society of North ...
ByQynapse
BOSTON, MA, November 4, 2021, PRNewswire – Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, is pleased to sponsor the 14th Clinical Trials on Alzheimer’s Disease conference (CTAD) to be held from November 9-12, 2021, in Boston, MA. ...
ByQynapse
ODS Medical, Inc., a Montreal based medical technology company, is pleased to announce a new financing round to support product engineering and regulatory work. ODS Medical is bringing together the power of machine learning and molecular imaging to develop optical biopsy tools based on Raman spectroscopy. ...